Logo image of APLS

APELLIS PHARMACEUTICALS INC (APLS) Stock Analyst Ratings

NASDAQ:APLS - Nasdaq - US03753U1060 - Common Stock - Currency: USD

17.49  -0.05 (-0.29%)

After market: 17.49 0 (0%)

Buy % Consensus

81

ChartMill assigns a Buy % Consensus number of 81% to APLS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 43.91. This target is 151.08% above the current price.
APLS was analyzed by 28 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about APLS.
In the previous month the buy percentage consensus was at a similar level.
APLS was analyzed by 28 analysts, which is quite many. So the average rating should be quite meaningful.
APLS Historical Analyst RatingsAPLS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -87 -79 -71 -63 -55 -47 -39 -31 -23 -15 -7 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 17.4925.2542.8443.9178.75 - 44.37% 144.94% 151.08% 350.26%
APLS Current Analyst RatingAPLS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-04-21 RBC Capital Maintains Sector Perform -> Sector Perform
2025-04-02 ScotiaBank Maintains Sector Perform -> Sector Perform
2025-03-04 JP Morgan Maintains Overweight -> Overweight
2025-03-03 RBC Capital Maintains Sector Perform -> Sector Perform
2025-03-03 Wedbush Maintains Neutral -> Neutral
2025-03-03 Goldman Sachs Maintains Neutral -> Neutral
2025-03-03 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-13 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-29 RBC Capital Maintains Sector Perform -> Sector Perform
2025-01-21 RBC Capital Reiterate Sector Perform -> Sector Perform
2025-01-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-17 Goldman Sachs Downgrade Buy -> Neutral
2024-11-21 Morgan Stanley Initiate Equal-Weight
2024-11-07 Baird Maintains Outperform -> Outperform
2024-11-06 ScotiaBank Maintains Sector Perform -> Sector Perform
2024-11-06 Needham Maintains Buy -> Buy
2024-11-06 Oppenheimer Maintains Outperform -> Outperform
2024-11-06 RBC Capital Maintains Sector Perform -> Sector Perform
2024-11-06 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-11-06 Goldman Sachs Maintains Buy -> Buy
2024-11-06 B of A Securities Maintains Buy -> Buy
2024-11-06 Piper Sandler Maintains Neutral -> Neutral
2024-11-06 Citigroup Maintains Buy -> Buy
2024-11-06 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-04 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-10-24 Mizuho Maintains Neutral -> Neutral
2024-10-16 William Blair Initiate Outperform
2024-10-16 ScotiaBank Initiate Sector Perform
2024-09-24 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2024-09-23 Baird Maintains Outperform -> Outperform